DiSante Jessica L, Bires Angela Macci, Cline Thomas W, Waterstram-Rich Kristen
South Hills Physical Medicine, Pittsburgh, Pennsylvania (Dr DiSante); School of Nursing and Health Sciences and Nuclear Medicine Technology Program, Robert Morris University, Moon Township, Pennsylvania (Dr Macci Bires); Saint Vincent College, Latrobe, Pennsylvania (Dr Cline); and College of Health Sciences and Technology, Rochester Institute of Technology, Rochester, New York (Ms Waterstram-Rich).
Crit Care Nurs Q. 2017 Apr/Jun;40(2):124-136. doi: 10.1097/CNQ.0000000000000149.
Coronary artery disease (CAD) is the leading cause of death in the United States. The World Bank and the World Health Organization predict that depression and coronary heart disease will be the largest causes of global health burden and disability by the year 2020. Studies have demonstrated that patients with CAD experience depression at a higher rate than the general population. Because of this connection, it is critical to recognize depression and manage depression effectively for people with CAD. Studies have also provided evidence that identifying and treating depression in patients early after a myocardial infarction improve clinical outcomes. In addition, a number of studies have discussed the negative effects that can occur from untreated depression in these patients. The cited negative effects include mortality, recurrent myocardial events, and a worse quality of life. This article discusses the results of a research that was completed at a cardiology office using a retroactive medical record review that focused on outpatients with cardiac diseases. The primary aim of the study was to collect data using the Patient Health Questionnaire-9 (PHQ-9), a public domain screening tool. This research was intended to provide evidence that would support using the PHQ-9 as a standard depression screening tool for patients post-myocardial infarction. By recognizing the symptoms of depression, the patient would then be treated accordingly.
冠状动脉疾病（CAD）是美国头号死因。世界银行和世界卫生组织预测，到2020年，抑郁症和冠心病将成为全球健康负担和残疾的最大成因。研究表明，CAD患者患抑郁症的比例高于普通人群。鉴于这种关联，识别并有效管理CAD患者的抑郁症至关重要。研究还提供了证据，表明在心肌梗死后早期识别并治疗患者的抑郁症可改善临床结局。此外，多项研究探讨了这些患者未经治疗的抑郁症可能产生的负面影响。所提及的负面影响包括死亡率、心肌事件复发以及生活质量较差。本文讨论了一项在心脏病诊所完成的研究结果，该研究采用回顾性病历审查，重点关注患有心脏病的门诊患者。该研究的主要目的是使用患者健康问卷-9（PHQ-9）这一公共领域筛查工具收集数据。这项研究旨在提供证据，支持将PHQ-9用作心肌梗死后患者的标准抑郁症筛查工具。通过识别抑郁症症状，患者便可得到相应治疗。
